a world of opportunities

Innovation is a key to strengthen Fidia's portfolio and a prerequisite for the success of our customers and partners.

Continually working to identify new treatment opportunities is the framework of our commitment to patients.

High on the company's list of priorities is the study of hyaluronic acid, a molecule that at Fidia means tradition, innovation, excellence.,

By modifying its chemistry, new products and innovative drug delivery systems and technology platforms are formulated that consolidate Fidia's leadership in areas such as joint healthcare, advanced wound care and aesthetic dermatology.

Fidia is continually working to identify new opportunities and develop an industry-leading pipeline of promising new treatments for specific pathologies in highly challenging areas, with products covered by international patents, that are a vital part of the company's heritage, as well as innovative formulations that will enhance their characteristics, without compromising the quality of care.

Over 1,300 patents worldwide.

More than 1.100 patents on hyaluronic acid and its applications.

Breakthrough patented technology processes, equipment and know- how.


Find out more about Fidia’s product portfolio:

Go to the website


Fidia Farmaceutici has a specific module dedicated to Pharmaco-Vigilance in order to promptly reporting of suspected adverse reactions. If you suspect that you have had an adverse reaction while taking one of our products or you have found defects

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint care
- ophthalmology
- active wound care
- neuroscience
- aesthetic medicine